Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.

Autor: Gal O; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel., Lewin R; Chaim Sheba Medical Center, Tel Hashomer, Israel., Perl G; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel., Ulitzky O; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel., Brenner B; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kundel Y; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2024 Jan 01; Vol. 20 (1), pp. 281-284. Date of Electronic Publication: 2023 Apr 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using ¹⁸ F-FDG PET-CT imaging: a prospective cohort study.

Autor: Brenner B; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel., Kundel Y; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Cohen Z; Felsenstein Medical Research Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Brand H; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Gordon N; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Sulkes A; Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel., Morgenstern S; Institute of Pathology, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Menasherov N; Department of Surgery A, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Kashtan H; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel.; Departments of Surgery A and B, Beilinson Hospital, Rabin Medical Center, Petach Tiqva, Israel., Groshar D; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel.; Department of Nuclear Medicine, Rabin Medical Center, Beilinson Hospital, Petach Tiqva, Israel., Domachevsky L; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel.; Department of Nuclear Medicine, Rabin Medical Center, Beilinson Hospital, Petach Tiqva, Israel.; Department of Nuclear Medicine, The Chaim Sheba Medical Center, Tel Hashomer, Israel., Bernstine H; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel.; Department of Nuclear Medicine, Rabin Medical Center, Beilinson Hospital, Petach Tiqva, Israel.

Publikováno v: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2022 Dec; Vol. 13 (6), pp. 2721-2735.

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer.

Autor: Zlotnik O; Department of Surgery, Rabin Medical Center, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Goshen-Lago T; Oncology Division, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, Technion, Haifa, Israel., Haddad R; Rappaport Faculty of Medicine, Technion, Haifa, Israel.; Department of Surgery, Carmel Medical Center, Haifa, Israel., Brenner B; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel., Kundel Y; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel., Ben-Aharon I; Oncology Division, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, Technion, Haifa, Israel., Kashtan H; Department of Surgery, Rabin Medical Center, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Mar; Vol. 5 (3), pp. e1489. Date of Electronic Publication: 2021 Aug 05.

Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.

Autor: Solomon D; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Abbas M; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Feferman Y; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Haddad R; Department of Surgery, Carmel Carmel Medical Center, Affiliated with the Rappaport Faculty of Medicine, Technion, Haifa, Israel., Perl G; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kundel Y; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Morgenstern S; Department of Pathology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Menasherov N; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kashtan H; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel. hkashtan@clalit.org.il.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. hkashtan@clalit.org.il.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2021 Sep; Vol. 28 (9), pp. 4929-4940. Date of Electronic Publication: 2021 Mar 11.